• Neuroligin 1 Loss Drives PKC-Linked Repetitive Behaviors in

  2026-06-26

  This study uncovers that Neuroligin 1 deficiency in striatal D2 medium spiny neurons leads to overactivation of protein kinase C (PKC), which drives excessive repetitive behaviors relevant to autism spectrum disorder (ASD). The findings provide direct mechanistic links between synaptic adhesion molecules, striatal circuitry, and PKC signaling in the emergence of autistic-like behaviors, suggesting new avenues for targeted intervention.

• Bone Transport Accelerates Diabetic Ulcer Healing via TGF-β1

  2026-06-26

  This study demonstrates that bone transport markedly improves diabetic foot ulcer healing by activating TGF-β1–mediated angiogenic and osteo-immune coupling. The findings clarify the central role of the TGF-β1/TGFBR1 pathway in coupling tissue repair processes, suggesting targeted pathway modulation as a promising therapeutic strategy.

• Amikacin Disulfate: Applied Workflows in Protein–Antibiotic

  2026-06-25

  Amikacin disulfate delivers unique value for dissecting the mechanisms of bacterial protein synthesis suppression and protein–antibiotic interactions. Recent advances in tritium-labeling and multimodal binding studies unlock new troubleshooting and optimization strategies for resistance research.

• Intravesical p21 mRNA-LNP Therapy for Localized Bladder Canc

  2026-06-25

  This study demonstrates that intravesical administration of p21 mRNA-loaded lipid nanoparticles (LNPs) restores tumor suppressor activity and suppresses tumor growth in non–muscle-invasive bladder cancer. The work pioneers a clinically compatible, localized gene therapy that leverages direct mRNA delivery for targeted tumor suppression, with mechanistic validation and translational promise.

• KCNE4 Modulation Alters Kv1.3 Blocker Pharmacology in Leukoc

  2026-06-24

  This study systematically investigates how the auxiliary subunit KCNE4 alters the pharmacological properties and inhibition kinetics of Kv1.3 channels, a central target in immune cell modulation. The findings reveal that KCNE4 slows the intracellular blockade kinetics of Psora 4 without affecting its binding affinity, highlighting the structural and functional complexity of Kv1.3 in leukocyte subtypes and its implications for selective immunomodulation strategies.

• Ultrasonically Powered Implantable TTF: Advancing Localized

  2026-06-23

  The referenced study introduces an ultrasonically powered, battery-free implantable Tumor Treating Field (i-TTF) system for enhanced glioblastoma therapy. By employing a shape-optimized BaTiO3 nanoparticle pyramid receiver, the device achieves superior wireless power transfer and localized electric field delivery, overcoming significant limitations of scalp-based TTF systems.

• Caspase-3 Colorimetric Assay Kit: Protocol & Troubleshooting

  2026-06-23

  The Caspase-3 Colorimetric Assay Kit enables rapid, sensitive quantification of DEVD-dependent caspase-3 activity, supporting apoptosis assay workflows in cell and tissue lysates. It is best suited for research focused on the caspase signaling pathway, apoptosis, and neurodegenerative disease models—not contexts where non-caspase-3 proteases or alternative apoptotic markers are primary endpoints.

• Mitocytosis Modulation Enhances Mitochondria-Targeted Antime

  2026-06-22

  This article examines a recent study that reveals how inhibiting mitocytosis—a stress response pathway in metastatic tumor cells—potentiates the efficacy of mitochondria-targeted drug delivery systems against breast cancer metastasis. The findings provide a mechanistic rationale for combining mitocytosis inhibition with mitochondrial damage to overcome resistance in highly migratory cancer models.

• Carboxylesterase Interference in Amplex Red-Based Mitochondr

  2026-06-22

  This study reveals that carboxylesterases can convert Amplex Red to resorufin independently of hydrogen peroxide and horseradish peroxidase, challenging the specificity of this widely used fluorescence assay for mitochondrial H2O2 measurement. The findings necessitate revised protocols and careful interpretation of prior oxidative stress data, with direct implications for redox and ROS research.

• Tobramycin as a Molecular Probe: Advancing Gram-Negative Res

  2026-06-21

  Explore Tobramycin, a leading aminoglycoside antibiotic, as a molecular probe in Gram-negative bacterial research. This article delivers advanced insights into its mechanism, experimental optimization, and strategic use in resistance studies—offering a perspective distinct from existing protocol-focused resources.

• Jasplakinolide (SKU B7189): Reliable Actin Polymerization In

  2026-06-20

  This article explores real-world laboratory scenarios where Jasplakinolide (SKU B7189) from APExBIO addresses critical challenges in actin cytoskeleton research, cell viability, and cytotoxicity assays. Through scenario-based Q&A, we demonstrate practical protocol guidance, data-backed performance metrics, and considerations for product selection—empowering life science researchers to achieve reproducible results.

• γH2AX DNA Damage Detection Kit: Precision in DNA Break Analy

  2026-06-19

  The γH2AX DNA Damage Detection Kit enables sensitive detection of DNA double-strand breaks via immunofluorescence. Using a mouse monoclonal antibody targeting γ-H2AX, this kit provides robust quantification of DNA damage and repair, supporting apoptosis and genotoxicity research. Its workflow is validated for reproducibility in both cell and tissue models.

• ROS-Degradable Lipid Nanoparticles Enable Tumor-Selective mR

  2026-06-19

  This study introduces a combinatorial library of biodegradable lipid nanoparticles responsive to reactive oxygen species (ROS) for the selective delivery of mRNA into tumor cells. By leveraging tumor-specific ROS levels, the research demonstrates a strategy for enhanced gene expression and effective mutant RAS pathway inhibition, providing a new direction in targeted mRNA therapeutics.

• Ampicillin Sodium: Applied β-Lactam Antibiotic Workflows & T

  2026-06-18

  Ampicillin sodium empowers researchers with reproducible antibacterial activity assays and advanced bacterial cell wall biosynthesis inhibition strategies. This article delivers actionable protocols, troubleshooting insights, and cross-study workflow integration to elevate experimental rigor with APExBIO’s high-purity β-lactam antibiotic.

• ALDH2 Activation Delays Heart Failure via Cardiomyocyte Prol

  2026-06-18

  This study demonstrates that ALDH2 activation, particularly with Alda 1, promotes proliferation of cardiomyocytes and extends their regenerative window in mice. The findings provide new mechanistic insight for cardiac ischemia research, highlighting ALDH2 as a promising target for heart failure intervention.

16386 records 1/1093 page Next 12345 下5页 Last page